Biodexa Pharmaceuticals Plc
Price Action
Technical Summary
WEAKENINGBiodexa Pharmaceuticals Plc is in a technical downtrend, trading below key resistance levels with a broken trend structure. Relative strength is weak (RS Rating: 2), showing significant lag compared to the market leaders. Earnings growth of 100% provides fundamental context to the price action. However, price is extended 26% above the 50-day line, increasing the risk of a mean reversion.
Trend Template (Minervini)
Price vs Moving Averages
| Period | Value | Spread | Signal |
|---|---|---|---|
| 20 SMA | $3.60 | +35.11% | ABOVE |
| 50 SMA | $3.85 | +26.34% | ABOVE |
| 100 SMA | $7.63 | -36.34% | BELOW |
| 150 SMA | $15.40 | -68.45% | BELOW |
| 200 SMA | $19.92 | -75.60% | BELOW |
Price Performance
Technical Indicators
Risk Profile
Volume Analysis
Earnings Momentum
Growth Trends
Compounded Sales Growth
Compounded Profit Growth
Stock Price CAGR
Return on Equity
Key Metrics
Frequently Asked Questions
Is BDRX in an uptrend right now?
BDRX has a trend score of 1/4 based on Minervini's Stage Analysis. Currently showing broken structure - 1 of 4 trend criteria are met.
Is BDRX overbought or oversold?
BDRX's RSI (14) is 60. The stock is in neutral territory, neither overbought nor oversold.
Is BDRX outperforming the market?
BDRX has a Relative Strength (RS) Rating of 2 out of 99. BDRX is currently lagging the broader market.
Where is BDRX in its 52-week range?
BDRX is trading at $4.86, which is 5% of its 52-week high ($96.50) and 3% above its 52-week low ($2.10).
How volatile is BDRX?
BDRX has a Beta of 1.25 and 52-week volatility of 189%. It's more volatile than the S&P 500 - expect bigger swings.